Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 12, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Left atrial appendage closure.

Inder M Singh1, David R Holmes

  • 1Mayo Clinic, Rochester, MN 55905, USA. singh.inder@mayo.edu

Current Cardiology Reports
|June 15, 2010
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Art and science.

Journal of the American College of Cardiology·2014
Same author

Fundamental concepts of effective troponin use: important principles for internists.

The American journal of medicine·2014
Same author

A prospective randomized controlled study of erythromycin on gastric and small intestinal distention: implications for MR enterography.

European journal of radiology·2014
Same author

Delayed transcatheter heart valve migration and failure.

JACC. Cardiovascular imaging·2014
Same author

Aortic valve replacement for severe aortic valve stenosis in the nonagenarian patient.

The Annals of thoracic surgery·2014
Same author

Snake eyes.

Journal of the American College of Cardiology·2014

Atrial fibrillation stroke prevention is crucial. Left atrial appendage closure devices offer a promising alternative to anticoagulants like warfarin, improving stroke risk management.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Medical Devices

Background:

  • Atrial fibrillation (AF) poses a significant stroke risk, necessitating effective prevention strategies.
  • Current anticoagulants like warfarin have limitations, including narrow therapeutic windows and bleeding risks.
  • Thromboemboli often originate from the left atrial appendage (LAA), making LAA exclusion a key target.

Purpose of the Study:

  • To review the role of left atrial appendage (LAA) closure devices in stroke prevention for atrial fibrillation (AF) patients.
  • To evaluate LAA closure as an alternative or adjunct to pharmacotherapy.
  • To discuss the current status and future potential of LAA closure technologies.

Main Methods:

  • Review of existing clinical data and randomized trials on LAA closure devices.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

Related Experiment Videos

Last Updated: Jun 12, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

  • Analysis of device efficacy and safety compared to pharmacologic stroke prevention.
  • Assessment of surgical LAA exclusion techniques.

    • Main Results:

    • Percutaneous LAA closure devices are emerging as viable options for stroke prevention in AF.
    • The WATCHMAN device shows promising randomized data.
    • Other LAA closure devices are in various stages of development.

    Conclusions:

    • Left atrial appendage closure represents a significant advancement in AF stroke prevention.
    • Device-based LAA closure offers a compelling alternative to traditional anticoagulation.
    • Continued research and development are essential for optimizing LAA closure therapies.